Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Mometasone Furoate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 known ✓ | P04150 | 6/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.77 |
| ▸ | LMNA | P02545 | 4/20 | 0.77 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.77 |
| ▸ | ABCB11 | O95342 | 3/20 | 0.77 |
| ▸ | PGR | P06401 | 3/20 | 0.77 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.77 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.77 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.77 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.77 |
| ▸ | AR | P10275 | 1/20 | 0.77 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.77 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.77 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.77 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.67 |
| ▸ | CNR1 | P21554 | 1/20 | 0.67 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.67 |
| ▸ | USP2 | O75604 | 3/20 | 0.60 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dexamethasone Acefurate SCHEMBL139744 | 0.89 | NR3C1 (0.69) | CYP3A4NR3C1LMNACYP2C9ABCB11 | |
| Mometasone Furoate SCHEMBL6414123 | 0.89 | CYP3A4 (0.84) | CYP3A4NR3C1LMNACYP2C9ABCB11 | |
| Amcinonide SCHEMBL18116084 | 0.89 | CYP3A4 (0.70) | CYP3A4NR3C1LMNACYP2C9ABCB11 | |
| SCHEMBL11037205 | 0.89 | NR3C1 (0.83) | CYP3A4NR3C1LMNACYP2C9ABCB11 | |
| Mometasone Furoate SCHEMBL25382496 | 0.88 | CYP3A4 (1.00) | CYP3A4NR3C1LMNACYP2C9ABCB11 | |
| Mometasone Furoate SCHEMBL7436523 | 0.88 | CYP3A4 (1.00) | CYP3A4NR3C1LMNACYP2C9ABCB11 | |
| Mometasone Furoate SCHEMBL8430908 | 0.88 | CYP3A4 (1.00) | CYP3A4NR3C1LMNACYP2C9ABCB11 | |
| Mometasone Furoate SCHEMBL13026146 | 0.88 | CYP3A4 (1.00) | CYP3A4NR3C1LMNACYP2C9ABCB11 | |
| Mometasone Furoate SCHEMBL4568 | 0.88 | CYP3A4 (1.00) | CYP3A4NR3C1LMNACYP2C9ABCB11 | |
| Mometasone Furoate SCHEMBL4896227 | 0.88 | CYP3A4 (1.00) | CYP3A4NR3C1LMNACYP2C9ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012017370-A1 | A MEDICINAL FUSIDIC ACID CREAM MADE USING SODIUM FUSIDATE AND INCORPORATING A BIOPOLYMER, BETAMETHASONE DIPROPIONATE, TERBINAFINE HYDROCHLORIDE AND A PROCESS TO MAKE IT | VANANGAMUDI SULUR SUBRAMANIAM (IN) | 2012-02-09 | — | — | WO | disclosed |